Transforming ALS Diagnosis and Drug Discovery
Breakthrough diagnosis and treatments
—reimagining ALS care with cutting-edge technology.
Scroll
About SONoALS
Mission-Driven Science
SONoALS, Inc. is a pioneering startup to redefine how ALS is diagnosed and treated. Our mission is to bring non-invasive, data-rich monitoring to the frontlines of neurodegenerative disease research. The team unites clinical neuroscience and biomedical engineering to make that mission a reality.
Breakthrough Technology
Wearable Ultrasound × AI-Powered Analysis
Revolutionary ultrasound technology combined with AI-powered analysis for Amyotrophic Lateral Sclerosis (ALS) monitoring and diagnosis.
Wearable Ultrasound Device Prototype
- Minimized ultrasound probe via a hub, allowing direct attachment to the skin
- Connectable to a laptop for simultaneous 4-muscle measurement & recording for 20 minutes in a resting state
- Acquired data is sent to the AI analysis server to display results
Overall View
詳細を見る
Probe & Hub Close-up
詳細を見る
Probe Close-up 1
詳細を見る
Probe Close-up 2
詳細を見るApplication & Measurement Images
Attachment State 1
詳細を見る
Attachment State 2
詳細を見る
Attachment State 3
詳細を見るPrecision Tools for ALS Research and Beyond
Transforming healthcare through innovative applications in early diagnosis and drug discovery.
Applications
Early and Non-invasive Diagnosis of ALS
- Fasciculations are one of the signs that appear earlier than needle EMG abnormalities.
Drug Discovery Support
Fasciculation biomarkers responding in days
- Pre-clinical drug screening in humans
- Selection of responder groups
- Significant reduction in clinical trial enrollment duration
We aim to realize these goals.
News & Press
Latest updates and achievements from SONoALS
Pitched at the 4th "Financial Committee" × "Kobe Innovation Community" MEET UP!
Delivered a pitch presentation and participated in the networking session at the 4th "Financial Committee" × "Kobe Innovation Community" MEET UP! held at Kigyoplaza Hyogo.
Appointed as International Committee Member of the Japan ALS Association
CEO Chizu Saeki has been appointed as an International Committee Member of the Japan ALS Association (JALSA).
Pitched at the Financial Committee Closed Pitch
CEO Saeki delivered a pitch at the Financial Committee Closed Pitch (Jul 13, 15:30–16:00) held at Kigyoplaza Hyogo ExitRoom.
Get in Touch
Ready to learn more about our revolutionary ALS technology? Let's connect.
Company Information
Address
WALLSQUARE Kitanozaka
2-13-15 Yamamoto Ave., Chuo Ward
Kobe City, Hyogo 650-0003, Japan
Established
May 2025
Tadashi Kojima
CTO/COO, SONoALS